Expiratory variability index is associated with asthma risk, wheeze and lung function in infants with recurrent respiratory symptoms.

Authors :: Seppä VP
Gracia-Tabuenca J
Kotaniemi-Syrjänen A
Malmström K
Hult A
Pelkonen AS
Mäkelä MJ
Viik J
Malmberg LP
Source :: ERJ open research [ERJ Open Res] 2020 Oct 19; Vol. 6 (4). Date of Electronic Publication: 2020 Oct 19 (Print Publication: 2020).
Publication Year :: 2020
Abstract: Impedance pneumography enables the measurement of the expiratory variability index (EVI) at home during a night's sleep in infants with recurrent respiratory symptoms. EVI is associated with asthma risk, symptoms and lung function. https://bit.ly/2PF2cx8.<br />Competing Interests: Conflict of interest: V-P. Seppä reports three patents with royalties paid to Revenio Group Inc. and is an employee of Revenio Group Inc., which commercialises impedance pneumography technology. Conflict of interest: J. Gracia Tabuenca has nothing to disclose. Conflict of interest: A. Kotaniemi-Syrjänen has nothing to disclose. Conflict of interest: K. Malmström has nothing to disclose. Conflict of interest: A. Hult is an employee of Revenio Group Inc., which commercialises impedance pneumography technology. Conflict of interest: A.S. Pelkonen has nothing to disclose. Conflict of interest: M.J. Mäkelä has nothing to disclose. Conflict of interest: J. Viik has three patents with royalties paid to Revenio Group Inc. Conflict of interest: L.P. Malmberg has nothing to disclose.<br /> (Copyright ©ERS 2020.)

Full Text Access

Tools